Associate Professor Judith Trotman

Clinical Associate Professor
Medicine, Concord Clinical School

Telephone +61 2 9767 5449
Fax +61 2 9767 7650

Map

Biographical details

Associate Professor Judith Trotman, MBChB, FRACP, FRCPA, Spec Cert in Clinical Research (Oncology), is a Senior Staff Specialist and Director, Clinical Research Unit in the Haematology Department, Concord Hospital. With a particular interest in lymphoma care, she has built a broad portfolio of trials across the spectrum of lymphoid malignancies. Dr Trotman worked as a scholar and clinician in 2009-2010 in the Clinical Research Unit in Lyon, France, within LYSA, the world leading French lymphoma trials collaborative. Her own research demonstrating the predictive power of PET-CT response assessment after first-line therapy in PRIMA, the world’s largest clinical trial in Follicular Lymphoma, has impacted on NCCN guidelines and was recently published in the Journal of Clinical Oncology. Dr Trotman returned to Concord convinced that we have the capacity to build a comprehensive lymphoma research portfolio and deliver “World’s best care, Locally”. Committed to both Australian based research and international collaborations she is the ALLG (Australian Leukaemia and Lymphoma Group), Principal Investigator for two international studies: the UK led, NHMRC funded, Response Adapted Therapy in Hodgkin’s Lymphoma study (RATHL-HD8), and the French led, REMARC-NHL25 study of Lenalidomide maintenance for older patients with diffuse large B cell lymphoma. She is also the Principal Investigator in the international FOLLCOLL study of PET scanning in Follicular Lymphoma, and of an ALLG world-first study of PET-adapted therapy for patients with relapsed Follicular Lymphoma. Other national research collaborations include the pharmacokinetics of High Dose Melphalan, the chemotherapy conditioning regimen used before autologous transplantation in Myeloma.

Teaching and supervision

Since 2003 A/Prof Trotman has been a tutor, lecturer and the coordinator of the Stage I, Haematology Block, in the Sydney Medical Program. This five week program provides Concord medical students with their first full-time exposure to learning in the Hospital environment. The shared commitment by her and her Concord Haematology colleagues to this program is evidenced by excellent student feedback and performance in RFAs. She is also extensively involved in post graduate teaching for both RACP and RCPA trainees. For 10 years she has been an invited lecturer in haematologic malignancies at the Aljessal/RPAH course for basic physician trainees.

Selected grants

2006

  • Using melphalan blood concentrations to reduce toxicity and improve transplant outcome in adult myel; Trotman J, Nath C, Shaw P, Kerridge I; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Tychyj-Pinel, C., Ricard, F., Fulham, M., Fournier, M., Meignan, M., Lamy, T., Vera, P., Salles, G., Trotman, J. (2014). PET/CT assessment in follicular lymphoma using standardized criteria: Central review in the PRIMA study. European Journal of Nuclear Medicine and Molecular Imaging, 41(3), 408-415. [More Information]
  • Karikios, D., Schofield, D., Salkeld, G., Mann, K., Trotman, J., Stockler, M. (2014). Rising cost of anticancer drugs in Australia. Internal Medicine Journal, 44(5), 458-463. [More Information]
  • Seymour, J., Trotman, J., Hofman, M. (2013). Evaluating the place of 18-fluoro-2-deoxy-d-glucose positron emission tomography scanning in primary staging and beyond in patients with follicular lymphoma. Leukemia and lymphoma, 54(10), 2093-2095. [More Information]
  • Gasiorowski, R., Gibson, J., Watson, G., Trotman, J., Larsen, S. (2013). Rapidly fatal post-allogeneic stem cell transplant lymphoproliferative disorder presenting with skin and bone marrow involvement. Pathology, 45(1), 81-83. [More Information]
  • Kiely, B., McCaughan, G., Christodoulou, S., Beale, P., Grimison, P., Trotman, J., Tattersall, M., Stockler, M. (2013). Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Supportive Care in Cancer, 21(2), 369-376. [More Information]
  • Trotman, J., Fournier, M., Lamy, T., Seymour, J., Sonet, A., Janíkova, A., Shpilberg, O., Gyan, E., Tilly, H., Estell, J., Fulham, M., et al (2011). Positron Emission Tomography-Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants. Journal of Clinical Oncology, 29(23), 3194-3200. [More Information]
  • Nath, C., Shaw, P., Trotman, J., Zeng, L., Duffull, S., Hegarty, G., McLachlan, A., Gurney, H., Kerridge, I., Kwan, Y., Joshua, D., et al (2010). Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy. British Journal of Clinical Pharmacology, 69(5), 484-497. [More Information]
  • Michallet, A., Trotman, J., Tychyj-Pinel, C. (2010). Role of early PET in the management of diffuse large B-cell lymphoma. Current Opinion in Oncology, 22(5), 414-8. [More Information]
  • Nath, C., Zeng, L., Eslick, A., Trotman, J., Earl, J. (2008). An isocratic UV HPLC assay for analysis of total and free melphalan concentrations in human plasma. Acta Chromatographicae, 20(3), 383-398. [More Information]
  • Trotman, J., Presgrave, P., Kwan, Y., Tiley, C., Estell, J., Watson, A., O'Brien, T., Peters, D. (2008). Consensus guidelines for 'rainy day' autologous stem cell harvests in New South Wales. Internal Medicine Journal, 38(4), 229-234. [More Information]
  • Chung, T., Lim, W., Sy, R., Cunningham, I., Trotman, J., Kritharides, L. (2008). Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function. Heart, 94(7), 911-918. [More Information]

2014

  • Tychyj-Pinel, C., Ricard, F., Fulham, M., Fournier, M., Meignan, M., Lamy, T., Vera, P., Salles, G., Trotman, J. (2014). PET/CT assessment in follicular lymphoma using standardized criteria: Central review in the PRIMA study. European Journal of Nuclear Medicine and Molecular Imaging, 41(3), 408-415. [More Information]
  • Karikios, D., Schofield, D., Salkeld, G., Mann, K., Trotman, J., Stockler, M. (2014). Rising cost of anticancer drugs in Australia. Internal Medicine Journal, 44(5), 458-463. [More Information]

2013

  • Seymour, J., Trotman, J., Hofman, M. (2013). Evaluating the place of 18-fluoro-2-deoxy-d-glucose positron emission tomography scanning in primary staging and beyond in patients with follicular lymphoma. Leukemia and lymphoma, 54(10), 2093-2095. [More Information]
  • Gasiorowski, R., Gibson, J., Watson, G., Trotman, J., Larsen, S. (2013). Rapidly fatal post-allogeneic stem cell transplant lymphoproliferative disorder presenting with skin and bone marrow involvement. Pathology, 45(1), 81-83. [More Information]
  • Kiely, B., McCaughan, G., Christodoulou, S., Beale, P., Grimison, P., Trotman, J., Tattersall, M., Stockler, M. (2013). Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Supportive Care in Cancer, 21(2), 369-376. [More Information]

2011

  • Trotman, J., Fournier, M., Lamy, T., Seymour, J., Sonet, A., Janíkova, A., Shpilberg, O., Gyan, E., Tilly, H., Estell, J., Fulham, M., et al (2011). Positron Emission Tomography-Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants. Journal of Clinical Oncology, 29(23), 3194-3200. [More Information]

2010

  • Nath, C., Shaw, P., Trotman, J., Zeng, L., Duffull, S., Hegarty, G., McLachlan, A., Gurney, H., Kerridge, I., Kwan, Y., Joshua, D., et al (2010). Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy. British Journal of Clinical Pharmacology, 69(5), 484-497. [More Information]
  • Michallet, A., Trotman, J., Tychyj-Pinel, C. (2010). Role of early PET in the management of diffuse large B-cell lymphoma. Current Opinion in Oncology, 22(5), 414-8. [More Information]

2008

  • Nath, C., Zeng, L., Eslick, A., Trotman, J., Earl, J. (2008). An isocratic UV HPLC assay for analysis of total and free melphalan concentrations in human plasma. Acta Chromatographicae, 20(3), 383-398. [More Information]
  • Trotman, J., Presgrave, P., Kwan, Y., Tiley, C., Estell, J., Watson, A., O'Brien, T., Peters, D. (2008). Consensus guidelines for 'rainy day' autologous stem cell harvests in New South Wales. Internal Medicine Journal, 38(4), 229-234. [More Information]
  • Chung, T., Lim, W., Sy, R., Cunningham, I., Trotman, J., Kritharides, L. (2008). Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function. Heart, 94(7), 911-918. [More Information]

To update your profile click here. For support on your academic profile contact .